Polycystic ovarian syndrome - prognosis and outcomes

dc.contributor.authorHart, R.
dc.contributor.authorNorman, R.
dc.date.issued2006
dc.description.abstractPolycystic ovarian syndrome (PCOS) is a condition that is present in 5–6% of women of reproductive age. It has potentially profound implications for women with regard to anovulatory infertility and symptoms related to elevated androgen levels. In addition, in later life women are prone to significant health problems related to hyperinsulinaemia, with an excess risk for diabetes and cardiovascular risk factors. Evidence suggests that the adverse features of PCOS can be ameliorated with lifestyle intervention, such as diet and exercise, while further short-term benefits related to ovulation and cardiac risk factors may be derived from medication with metformin. Evidence for the long-term use of metformin to protect against adverse cardiovascular outcomes and for the use of metformin throughout pregnancy to reduce the risk of miscarriage, gestational diabetes, pre-eclampsia and fetal macrosomia is still lacking. Key words: PCOS; metabolic syndrome; infertility; diabetes; cardiovascular risk; metformin; androgens
dc.description.statementofresponsibilityRoger Hart and Robert Norman
dc.identifier.citationBest Practice and Research: Clinical Obstetrics and Gynaecology, 2006; 20(5):751-778
dc.identifier.doi10.1016/j.bpobgyn.2006.04.006
dc.identifier.issn1521-6934
dc.identifier.issn1532-1932
dc.identifier.orcidNorman, R. [0000-0002-3118-3896]
dc.identifier.urihttp://hdl.handle.net/2440/23209
dc.language.isoen
dc.publisherBailliere Tindall
dc.rights© 2006 Elsevier Ltd All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.bpobgyn.2006.04.006
dc.subjectPCOS
dc.subjectmetabolic syndrome
dc.subjectinfertility
dc.subjectdiabetes
dc.subjectcardiovascular risk
dc.subjectmetformin
dc.subjectandrogens
dc.titlePolycystic ovarian syndrome - prognosis and outcomes
dc.typeJournal article
pubs.publication-statusPublished

Files